This plasma metabolite, 2-(4-Methoxyphenyl)acetic acid, serves as a highly sensitive and specific biomarker for distinguishing non-small cell lung cancer (NSCLC) patients from healthy individuals. It is a valuable small molecule for research in oncology, metabolomics, and the development of diagnostic assays in both in vitro and clinical studies.
